{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:30:04Z","timestamp":1790659804088,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,9,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Population-based mammographic screening programmes have been operating for over 30 years and whilst many studies have assessed the short- to medium-term effectiveness of screening, few have assessed their long-term effectiveness. The aim of this study was to assess the long-term effectiveness of the NHS Breast Screening Programme in England and Wales.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>2,509,384 women aged 49\u201364 years and uninvited to screening upon study entry were studied, with screening status changing on invitation and attendance. Women were followed for breast cancer diagnosis and death for a maximum of 33 years. Poisson regression was used to assess the effect of screening on breast cancer incidence and mortality compared to an uninvited comparison group, and overdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After adjustment for confounders, invitation to screening was associated with a 28% reduction in breast cancer mortality (RR: 0.72; 95% CI: 0.71\u20130.74) and attendance at screening was associated with a 33% reduction (RR: 0.67; 95% CI: 0.65\u20130.69). There was a 4% excess of breast cancer diagnoses associated with being screened (RR: 1.04; 95% CI: 1.02\u20131.07) with at least 5 years follow-up post-screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings indicate that screening continues to be effective in reducing breast cancer mortality many years after cessation of screening and that the level of overdiagnosis associated with long-term follow-up is low.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03493-z","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:45:36Z","timestamp":1782506736000},"page":"964-971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Long-term effectiveness and overdiagnosis in the NHS breast screening programme: a cohort study with up to 33 years of follow-up"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0599-9840","authenticated-orcid":false,"given":"Amanda","family":"Dibden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8767-8364","authenticated-orcid":false,"given":"Dharmishta","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-3094","authenticated-orcid":false,"given":"Rhian","family":"Gabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-2238","authenticated-orcid":false,"given":"Robert A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue M.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2837-1682","authenticated-orcid":false,"given":"Louise E.","family":"Johns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-7922","authenticated-orcid":false,"given":"Stephen W.","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"3493_CR1","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0140-6736(85)92204-4","volume":"1","author":"L Tabar","year":"1985","unstructured":"Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985;1:829\u201332.","journal-title":"Lancet"},{"key":"3493_CR2","first-page":"349","volume":"69","author":"S Shapiro","year":"1982","unstructured":"Shapiro S, Venet W, Strax P, Venet L, Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982;69:349\u201355.","journal-title":"J Natl Cancer Inst"},{"key":"3493_CR3","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1148\/radiol.11110469","volume":"260","author":"L Tab\u00e1r","year":"2011","unstructured":"Tab\u00e1r L, Vitak B, Chen TH-H, Yen AM-F, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658\u201363.","journal-title":"Radiology"},{"key":"3493_CR4","doi-asserted-by":"crossref","unstructured":"Dibden A, Offman J, Duffy SW, Gabe R. Worldwide review and meta-analysis of cohort studies measuring the effect of mammography screening programmes on incidence-based breast cancer mortality. Cancers. 2020;12:976.","DOI":"10.3390\/cancers12040976"},{"key":"3493_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1258\/jms.2012.012080","volume":"19","author":"S Njor","year":"2012","unstructured":"Njor S, Nystrom L, Moss S, Paci E, Broeders M, Segnan N, et al. Breast cancer mortality in mammographic screening in Europe: a review of incidence-based mortality studies. J Med Screen. 2012;19:33\u201341.","journal-title":"J Med Screen"},{"key":"3493_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1258\/jms.2012.012078","volume":"19","author":"M Broeders","year":"2012","unstructured":"Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen. 2012;19:14\u201325.","journal-title":"J Med Screen"},{"key":"3493_CR7","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1038\/bjc.2013.177","volume":"108","author":"MG Marmot","year":"2013","unstructured":"Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M, et al. The benefits and harms of breast cancer screening: an independent review: a report jointly commissioned by Cancer Research UK and the Department of Health (England) October 2012. Br J Cancer. 2013;108:2205\u201340.","journal-title":"Br J Cancer"},{"key":"3493_CR8","unstructured":"IARC Working Group on the Evaulation of Cancer. Breast Cancer Screening. 2016."},{"key":"3493_CR9","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/bjc.2016.415","volume":"116","author":"LE Johns","year":"2017","unstructured":"Johns LE, Coleman DA, Swerdlow AJ, Moss SM. Effect of population breast screening on breast cancer mortality up to 2005 in England and Wales: an individual-level cohort study. Br J Cancer. 2017;116:246\u201352.","journal-title":"Br J Cancer"},{"key":"3493_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1177\/0969141317713232","volume":"25","author":"LE Johns","year":"2018","unstructured":"Johns LE, Swerdlow AJ, Moss SM. Effect of population breast screening on breast cancer mortality to 2005 in England and Wales: a nested case-control study within a cohort of one million women. J Med Screen. 2018;25:76\u201381.","journal-title":"J Med Screen"},{"key":"3493_CR11","doi-asserted-by":"crossref","unstructured":"UK Trial of Early Detection of Breast Cancer Group. 16-year mortality from breast cancer in the UK Trial of Early Detection of Breast Cancer. Lancet. 1999;353:1909\u201314.","DOI":"10.1016\/S0140-6736(98)07412-1"},{"key":"3493_CR12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41416-020-01163-2","volume":"124","author":"R Maroni","year":"2021","unstructured":"Maroni R, Massat NJ, Parmar D, Dibden A, Cuzick J, Sasieni PD, et al. A case-control study to evaluate the impact of the breast screening programme on mortality in England. Br J Cancer. 2021;124:736\u201343.","journal-title":"Br J Cancer"},{"key":"3493_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1055-9965.EPI-15-0803","volume":"25","author":"NJ Massat","year":"2016","unstructured":"Massat NJ, Dibden A, Parmar D, Cuzick J, Sasieni PD, Duffy SW. Impact of screening on breast cancer mortality: the UK program 20 Years On. Cancer Epidemiol Biomark Prev. 2016;25:455\u201362.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3493_CR14","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.bjc.6604123","volume":"98","author":"PC Allgood","year":"2008","unstructured":"Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer. 2008;98:206\u20139.","journal-title":"Br J Cancer"},{"key":"3493_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1258\/0969141042467304","volume":"11","author":"HM Fielder","year":"2004","unstructured":"Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen. 2004;11:194\u20138.","journal-title":"J Med Screen"},{"key":"3493_CR16","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1053\/j.sembd.2007.09.003","volume":"10","author":"SW Duffy","year":"2007","unstructured":"Duffy SW, Chen THH, Yen AMF, Tabar L, Gabe R, Smith RA. Methodologic Issues in the Evaluation of Service Screening. Semin Breast Dis. 2007;10:68\u201371.","journal-title":"Semin Breast Dis"},{"key":"3493_CR17","first-page":"23","volume":"11","author":"E Paci","year":"2004","unstructured":"Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? J Med Screen. 2004;11:23\u20137.","journal-title":"J Med Screen"},{"key":"3493_CR18","doi-asserted-by":"publisher","first-page":"e046353","DOI":"10.1136\/bmjopen-2020-046353","volume":"11","author":"D Chaltiel","year":"2021","unstructured":"Chaltiel D, Hill C. Estimations of overdiagnosis in breast cancer screening vary between 0% and over 50%: why? BMJ Open. 2021;11:e046353.","journal-title":"BMJ Open"},{"key":"3493_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/0895-4356(94)90089-2","volume":"47","author":"KC Chu","year":"1994","unstructured":"Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol. 1994;47:1451\u201361.","journal-title":"J Clin Epidemiol"},{"key":"3493_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0033-8389(22)02494-0","volume":"30","author":"L Tab\u00e0r","year":"1992","unstructured":"Tab\u00e0r L, Fagerberg G, Duffy SW, Day NE, Gad A, Gr\u00f6ntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radio Clin North Am. 1992;30:187\u2013210.","journal-title":"Radio Clin North Am"},{"key":"3493_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/1467-9876.00266","volume":"51","author":"Duffy","year":"2002","unstructured":"Duffy, Cuzick SW, Tabar J, Vitak L, Hsiu-Hsi B, Chen T, et al. Correcting for non-compliance bias in case\u2013control studies to evaluate cancer screening programmes. J R Stat Soc Ser C (Appl Stat). 2002;51:235\u201343.","journal-title":"J R Stat Soc Ser C (Appl Stat)"},{"key":"3493_CR22","unstructured":"StataCorp. Stata Statistical Software: Release 18. College Station, TX: StataCorp LLC; 2023."},{"key":"3493_CR23","doi-asserted-by":"publisher","first-page":"g3701","DOI":"10.1136\/bmj.g3701","volume":"348","author":"H Weedon-Fekjaer","year":"2014","unstructured":"Weedon-Fekjaer H, Romundstad PR, Vatten LJ. Modern mammography screening and breast cancer mortality: population study. Bmj. 2014;348:g3701.","journal-title":"Bmj"},{"key":"3493_CR24","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/bmj.314.7084.864","volume":"314","author":"M Hakama","year":"1997","unstructured":"Hakama M, Pukkala E, Heikkila M, Kallio M. Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. Bmj. 1997;314:864\u20137.","journal-title":"Bmj"},{"key":"3493_CR25","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/annonc\/mdg320","volume":"14","author":"SD Walter","year":"2003","unstructured":"Walter SD. Mammographic screening: case\u2013control studies. Ann Oncol. 2003;14:1190\u20132.","journal-title":"Ann Oncol"},{"key":"3493_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/09691413211059461","volume":"29","author":"MJ Yaffe","year":"2022","unstructured":"Yaffe MJ, Seely JM, Gordon PB, Appavoo S, Kopans DB. The randomized trial of mammography screening that was not-A cautionary tale. J Med Screen. 2022;29:7\u201311.","journal-title":"J Med Screen"},{"key":"3493_CR27","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1002\/cam4.5004","volume":"12","author":"O Blyuss","year":"2023","unstructured":"Blyuss O, Dibden A, Massat NJ, Parmar D, Cuzick J, Duffy SW, et al. A case-control study to evaluate the impact of the breast screening programme on breast cancer incidence in England. Cancer Med. 2023;12:1878\u201387.","journal-title":"Cancer Med"},{"key":"3493_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3332\/ecancer.2017.746","volume":"11","author":"F Ades","year":"2017","unstructured":"Ades F, Tryfonidis K, Zardavas D. The past and future of breast cancer treatment-from the papyrus to individualised treatment approaches. Ecancermedicalscience. 2017;11:746.","journal-title":"Ecancermedicalscience"},{"key":"3493_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.breast.2017.06.003","volume":"36","author":"G Carioli","year":"2017","unstructured":"Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality in Europe. Breast. 2017;36:89\u201395.","journal-title":"Breast"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03493-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03493-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:38:42Z","timestamp":1788277122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03493-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,9,20]]}},"alternative-id":["3493"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03493-z","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"23 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations, including UK GDPR, the Data Protection Act 2018. Ethical approval has been obtained from NRES Committee London - South East \u2013 reference number 02\/1\/064 and the study received approval under Section 251 of the NHS Act 2006 (to access data without informed consent) through the Confidentiality Advisory Group (CAG) \u2013 reference [\n                      \n                      ]\/CAG\/0160.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All reasonable measures have been taken to protect patient anonymity.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}